Get the Stockscreener App
5.74
4.17%
0.23
After Hours:
5.74
Inventiva Adr stock is traded at $5.74, with a volume of 653.64K.
It is up +4.17% in the last 24 hours and down -4.17% over the past month.
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.
See More
Previous Close:
$5.51
Open:
$5.52
24h Volume:
653.64K
Relative Volume:
1.40
Market Cap:
$1.19B
Revenue:
$4.90M
Net Income/Loss:
$-399.99M
P/E Ratio:
-2.0206
EPS:
-2.8407
Net Cash Flow:
$-122.90M
1W Performance:
+8.30%
1M Performance:
-4.17%
6M Performance:
+4.94%
1Y Performance:
+68.72%
1-Day Range:
$5.44
$5.80
1-Week Range:
$4.93
$5.80
52-Week Range:
$2.8536
$7.9825
Inventiva Adr Stock (IVA) Company Profile
Compare IVA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
5.74 | 1.14B | 4.90M | -399.99M | -122.90M | -2.8407 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-19-26 | Initiated | Truist | Buy |
| Jan-28-26 | Initiated | Barclays | Overweight |
| Jan-12-26 | Initiated | Leerink Partners | Outperform |
| Jan-07-26 | Resumed | UBS | Buy |
| Nov-06-25 | Initiated | Wolfe Research | Outperform |
| Sep-03-25 | Resumed | H.C. Wainwright | Buy |
| Aug-27-25 | Initiated | Piper Sandler | Overweight |
| Feb-21-25 | Initiated | TD Cowen | Buy |
| Nov-12-24 | Initiated | UBS | Neutral |
| Oct-27-23 | Initiated | Canaccord Genuity | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-19-23 | Upgrade | Societe Generale | Sell → Buy |
| Mar-17-23 | Initiated | Stifel | Buy |
| Nov-15-22 | Downgrade | Societe Generale | Buy → Sell |
| Mar-08-21 | Downgrade | Societe Generale | Buy → Sell |
| Aug-05-20 | Initiated | ROTH Capital | Buy |
| Aug-04-20 | Initiated | Guggenheim | Buy |
| Aug-04-20 | Initiated | Stifel | Buy |
View All
Inventiva Adr Stock (IVA) Latest News
Phreesia, Service Properties Trust, Inventiva and other big stocks moving lower in Tuesday's pre-market session - MSN
Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F - GlobeNewswire Inc.
Phreesia, Service Properties Trust, Inventiva And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Update - MarketBeat
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm
Does Inventiva (IVA) have the potential to rally 136.34% as Wall Street analysts expect? - MSN
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Sahm
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $17.00 Consensus PT from Brokerages - Defense World
Short Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Drops By 20.4% - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Average Rating of "Buy" from Analysts - MarketBeat
Does Inventiva (IVA) Have the Potential to Rally 136.34% as Wall Street Analysts Expect? - Finviz
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Sees Significant Increase in Short Interest - MarketBeat
Are You Looking for a Top Momentum Pick? Why Inventiva S.A. Sponsored ADR (IVA) is a Great Choice - Yahoo Finance
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Inventiva SA ADR Trade Ideas — LSX:A2P796 - TradingView
Inventiva (NASDAQ:IVA) Shares Gap Up on Analyst Upgrade - Defense World
Inventiva’s (IVA) “Buy” Rating Reiterated at UBS Group - Defense World
Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should Know - primepublishers.com
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Inventiva (NASDAQ:IVA) Sees Strong Trading VolumeHere's Why - MarketBeat
The time has not yet come to remove your chips from the table: Inventiva ADR (IVA) - setenews.com
Debt to assets ratio of Inventiva SA ADR – LSX:A2P796 - TradingView — Track All Markets
Net margin % of Inventiva SA ADR – LSX:A2P796 - TradingView
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Tilray Brands, SuperX AI Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Weekly Investment Analysts’ Ratings Changes for Inventiva (IVA) - Defense World
Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why LexinFintech Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Inventiva (NASDAQ:IVA) Price Target Cut to $11.00 by Analysts at Guggenheim - Defense World
ETFs Investing in Inventiva SA ADR Stocks - TradingView
Form 424B5 Inventiva S.A. - StreetInsider
Its Stock Has Paid Off Big Time For Inventiva ADR - Setenews
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Inventiva (NASDAQ:IVA) Upgraded at Wolfe Research - Defense World
Assemblée Générale Mixte du 27 novembre 2025 - GlobeNewswire Inc.
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Up 461.9% in October - MarketBeat
How Does Wall Street Rate Shares Of Inventiva ADR (IVA)? - fostersleader.com
Inventiva (NASDAQ:IVA) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Inventiva (NASDAQ:IVA) Raised to “Hold” at Wall Street Zen - Defense World
Inventiva Adr Stock (IVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):